CONMED (CNMD) Competitors

Stevanato Group (NYSE:STVN) and CONMED (NYSE:CNMD) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, community ranking, valuation, institutional ownership, risk, profitability, dividends, analyst recommendations and media sentiment.

Does the media prefer STVN or CNMD?

In the previous week, Stevanato Group had 4 more articles in the media than CONMED. MarketBeat recorded 8 mentions for Stevanato Group and 4 mentions for CONMED. CONMED's average media sentiment score of 1.74 beat Stevanato Group's score of 1.21 indicating that CONMED is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Stevanato Group	7 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
CONMED	4 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Does the MarketBeat Community believe in STVN or CNMD?

CONMED received 6 more outperform votes than Stevanato Group when rated by MarketBeat users. However, 62.50% of users gave Stevanato Group an outperform vote while only 47.37% of users gave CONMED an outperform vote.

Company	Underperform	Outperform
Stevanato Group	Outperform Votes 30 62.50%	Underperform Votes 18 37.50%
CONMED	Outperform Votes 36 47.37%	Underperform Votes 40 52.63%

Do analysts recommend STVN or CNMD?

CONMED has a consensus price target of $77.20, suggesting a potential upside of 29.31%. Given CONMED's higher probable upside, analysts plainly believe CONMED is more favorable than Stevanato Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Stevanato Group	0 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.71
CONMED	0 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.60

Is STVN or CNMD a better dividend stock?

Stevanato Group pays an annual dividend of €0.06 per share and has a dividend yield of 0.3%. CONMED pays an annual dividend of $0.80 per share and has a dividend yield of 1.3%. Stevanato Group pays out 12.5% of its earnings in the form of a dividend. CONMED pays out 18.9% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Which has more volatility & risk, STVN or CNMD?

Stevanato Group has a beta of 0.6, suggesting that its share price is 40% less volatile than the S&P 500. Comparatively, CONMED has a beta of 1.53, suggesting that its share price is 53% more volatile than the S&P 500.

Which has stronger valuation & earnings, STVN or CNMD?

Stevanato Group has higher earnings, but lower revenue than CONMED. CONMED is trading at a lower price-to-earnings ratio than Stevanato Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Stevanato Group	$1.10B	5.83	$157.62M	$0.48	44.29
CONMED	$1.31B	1.41	$132.42M	$4.24	14.08

Is STVN or CNMD more profitable?

Stevanato Group has a net margin of 10.47% compared to CONMED's net margin of 10.13%. CONMED's return on equity of 14.31% beat Stevanato Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Stevanato Group	10.47%	9.86%	5.79%
CONMED	10.13%	14.31%	5.64%

Summary

Stevanato Group beats CONMED on 10 of the 18 factors compared between the two stocks.